Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

23andMe Holding Co. to acquire Lemonaid Health

Announced Oct 22, 2021 · Closed Nov 2, 2021 · Private target

Deal value$400M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock

Transaction

Acquirer
23andMe Holding Co. (ME)
Target
Lemonaid Health
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Nov 2, 2021

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Allen & Company
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99.1) · Oct 22, 2021

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.